1 / 1

Innovative PCPCSK9 Rename: LDLC-Modulating Compound Analysis

Analyzing Relative Amounts of NPCSK9 and sPCSK9 against LDLR with Simvastatin treatment at varying concentrations in µM.

bluma
Download Presentation

Innovative PCPCSK9 Rename: LDLC-Modulating Compound Analysis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. A ProPCSK9 Non- specific mPCSK9 * 2.0 * * * * * 1.5 Relative Amount 1.8 1.7 1.0 1.6 1.5 1.4 1.3 0.5 1.1 1.1 1.0 1.0 1.0 1.0 0.0 0 0.01 0.05 1 5 10 B sPCSK9 2.0 2.0 1.5 1.5 C Relative Amount 1.6 1.6 1.0 1.0 LDLR 1.5 1.5 1.5 1.5 1.4 1.4 0.5 0.5 * 1.0 1.0 1.0 1.0 * 3.0 3.0 3.0 3.0 0.0 0.0 2.5 2.5 2.5 2.5 0 0 0.01 0.01 0.05 0.05 1 1 5 5 10 10 10 * 2.0 2.0 2.0 2.0 Relative Amount 2.6 2.6 2.6 2.6 2.6 2.6 2.6 2.6 1.5 1.5 1.5 1.5 2.0 2.0 2.0 2.0 1.0 1.0 1.0 1.0 1.1 1.1 1.1 1.1 0.5 0.5 0.5 0.5 1.1 1.1 1.1 1.1 1.0 1.0 1.0 1.0 0.0 0.0 0.0 0.0 0 0.01 0.01 0.01 0.01 0.05 0.05 0.05 0.05 1 1 1 1 10 10 10 10 5 5 5 5 Simvastatin µM

More Related